<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 12:      Results of Drug Interaction Studies with VIDEX: Effects of Coadministered Drug on Didanosine Plasma AUC and C<sub>max</sub> Values</caption>
<col width="25%"></col>
<col width="25%"></col>
<col width="10%"></col>
<col width="20%"></col>
<col width="20%"></col>
<thead>
<tr>
<th align="left" stylecode="Toprule " valign="bottom"></th>
<th align="left" stylecode="Toprule " valign="bottom"></th>
<th align="left" stylecode="Toprule " valign="bottom"></th>
<th align="center" colspan="2" stylecode="Botrule Toprule " valign="bottom">
<content stylecode="bold">% Change of Didanosine</content>
<br/>
<content stylecode="bold">Pharmacokinetic Parameters<sup>a</sup>
</content>
</th>
</tr>
<tr>
<th align="center" stylecode="Botrule " valign="bottom">
<content stylecode="bold">Drug</content>
</th>
<th align="center" stylecode="Botrule " valign="bottom">
<content stylecode="bold">Didanosine Dosage</content>
</th>
<th align="center" stylecode="Botrule " valign="bottom">
<content stylecode="bold">n</content>
</th>
<th align="center" stylecode="Botrule " valign="bottom">
<content stylecode="bold">AUC of </content>
<br/>
<content stylecode="bold">Didanosine</content>
<br/>
<content stylecode="bold">(95% CI)</content>
</th>
<th align="center" stylecode="Botrule " valign="bottom">
<content stylecode="bold">C<sub>max</sub> of </content>
<br/>
<content stylecode="bold">Didanosine</content>
<br/>
<content stylecode="bold">(95% CI)</content>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="5" stylecode="Botrule" valign="top">↑  Indicates increase.<br/>↓  Indicates decrease.<br/>↔  Indicates no change, or mean increase or decrease of less than 10%.<br/>
<sup>a</sup>  The 95% confidence intervals for the percent change in the pharmacokinetic parameter are displayed.<br/>
<sup>b</sup>  HIV-infected patients.<br/>
<sup>c</sup>  90% CI.<br/>
<sup>d</sup>  Comparisons are made to a parallel control group not receiving methadone (n=10).<br/>
<sup>e</sup>  Comparisons are made to historical controls (n=68, pooled from 3 studies) conducted in healthy subjects. The number of subjects evaluated for AUC and C<sub>max</sub> is 15 and 16, respectively.<br/>
<sup>f</sup>  For results of drug interaction studies between the enteric-coated formulation of didanosine (VIDEX EC) and methadone, see the complete prescribing information for VIDEX EC.<br/>
<sup>g</sup>  Tenofovir disoproxil fumarate.<br/>
<sup>h</sup>  For results of drug interaction studies between the enteric-coated formulation of didanosine (VIDEX EC) and tenofovir disoproxil fumarate, see the complete prescribing information for VIDEX EC.<br/>
<sup>i</sup>  Patients less than 60 kg with creatinine clearance of at least 60 mL/min.<br/>NA = Not available.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Toprule ">
<paragraph>
<content stylecode="bold">allopurinol</content>,</paragraph>
</td>
<td stylecode="Toprule "></td>
<td stylecode="Toprule "></td>
<td stylecode="Toprule "></td>
<td stylecode="Toprule "></td>
</tr>
<tr>
<td>
<paragraph>renally impaired, 300 mg/day</paragraph>
</td>
<td align="center">
<paragraph>200 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>2</paragraph>
</td>
<td align="center">
<paragraph>↑ 312%</paragraph>
</td>
<td align="center">
<paragraph>↑ 232%</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>healthy volunteer, 300 mg/day for 7 days</paragraph>
</td>
<td align="center">
<paragraph>400 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>14</paragraph>
</td>
<td align="center">
<paragraph>↑ 113%</paragraph>
</td>
<td align="center">
<paragraph>↑ 69%</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>ciprofloxacin, 750 mg every 12 hours for 3 days, 2 hours before didanosine</paragraph>
</td>
<td align="center">
<paragraph>200 mg every 12 hours<br/>for  3 days</paragraph>
</td>
<td align="center">
<paragraph>8<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↓ 16%</paragraph>
</td>
<td align="center">
<paragraph>↓ 28%</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<content stylecode="bold">ganciclovir</content>, 1000 mg every 8 hours, 2 hours after didanosine</paragraph>
</td>
<td align="center">
<paragraph>200 mg every 12 hours</paragraph>
</td>
<td align="center">
<paragraph>12</paragraph>
</td>
<td align="center">
<paragraph>↑ 111%</paragraph>
</td>
<td align="center">
<paragraph>NA</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>indinavir, 800 mg single dose, simultaneous</paragraph>
</td>
<td align="center">
<paragraph>200 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>16</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>1 hour before didanosine</paragraph>
</td>
<td align="center">
<paragraph>200 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>16</paragraph>
</td>
<td align="center">
<paragraph>↓ 17%<br/>(-27, -7%)<sup>c</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↓ 13%<br/>(-28, 5%)<sup>c</sup>
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>ketoconazole, 200 mg/day for 4 days, 2 hours before didanosine</paragraph>
</td>
<td align="center">
<paragraph>375 mg every 12 hours<br/>for 4 days</paragraph>
</td>
<td align="center">
<paragraph>12<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↓ 12%</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<content stylecode="bold">methadone</content>, chronic maintenance dose<sup>f</sup>
</paragraph>
</td>
<td align="center">
<paragraph>200 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>16<sup>d</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↓ 57%</paragraph>
</td>
<td align="center">
<paragraph>↓ 66%</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>400 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>15, 16<sup>e</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↓ 29%<br/>(-40, -16%)<sup>c</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↓ 41%<br/>(-54, -26%)<sup>c</sup>
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<content stylecode="bold">tenofovir</content>,<sup>g,h</sup> 300 mg once daily, 1 hour after didanosine</paragraph>
</td>
<td align="center">
<paragraph>250<sup>i</sup> mg or 400 mg once daily for 7 days</paragraph>
</td>
<td align="center">
<paragraph>14</paragraph>
</td>
<td align="center">
<paragraph>↑ 44%<br/>(31, 59%)<sup>c</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↑ 28%<br/>(11, 48%)<sup>c</sup>
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>loperamide, 4 mg every 6 hours for 1 day</paragraph>
</td>
<td align="center">
<paragraph>300 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>12<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↓ 23%</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>metoclopramide, 10 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>300 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>12<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↑ 13%</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>ranitidine, 150 mg single dose, 2 hours before didanosine</paragraph>
</td>
<td align="center">
<paragraph>375 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>12<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↑ 14%</paragraph>
</td>
<td align="center">
<paragraph>↑ 13%</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>rifabutin, 300 or 600 mg/day for 12 days</paragraph>
</td>
<td align="center">
<paragraph>167 mg or 250 mg every 12 hours for 12 days</paragraph>
</td>
<td align="center">
<paragraph>11</paragraph>
</td>
<td align="center">
<paragraph>↑ 13%<br/>(-1, 27%)</paragraph>
</td>
<td align="center">
<paragraph>↑ 17%<br/>(-4, 38%)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>ritonavir, 600 mg every 12 hours for 4 days</paragraph>
</td>
<td align="center">
<paragraph>200 mg every 12 hours<br/>for 4 days</paragraph>
</td>
<td align="center">
<paragraph>12</paragraph>
</td>
<td align="center">
<paragraph>↓ 13%<br/>(0, 23%)</paragraph>
</td>
<td align="center">
<paragraph>↓ 16%<br/>(5, 26%)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>stavudine, 40 mg every 12 hours for 4 days</paragraph>
</td>
<td align="center">
<paragraph>100 mg every 12 hours<br/>for 4 days</paragraph>
</td>
<td align="center">
<paragraph>10</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>sulfamethoxazole, 1000 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>200 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>8<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>trimethoprim, 200 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>200 mg single dose</paragraph>
</td>
<td align="center">
<paragraph>8<sup>b</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↔</paragraph>
</td>
<td align="center">
<paragraph>↑ 17%<br/>(-23, 77%)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>zidovudine, 200 mg every 8 hours for 3 days</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>200 mg every 12 hours<br/>for 3 days</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>6<sup>b</sup>
</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>↔</paragraph>
</td>
</tr>
</tbody>
</table>